Benjamin Gaborit

Université de Nantes

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Roberto Roncon‐Albuquerque

PORTUGAL

View details

Ted Steiner

Professor

The University of British Columbia

CANADA

View details

Antoine ASQUIER-KHATI

University Hospital

FRANCE

View details

Benoit Salomon

INSERM

FRANCE

View details

Xavier MONNET

Chief

Assistance Publique - Hôpitaux de Paris

FRANCE

View details

Giacomo Maria Guidelli

Assistant of professor

IRCCS Humanitas Research Hospital

ITALY

View details

Antoine Roquilly

Prof

University Hospital

FRANCE

View details

Philippe Le Conte

FRANCE

View details

Fabian Dusse

University Hospital Bonn

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Benjamin Gaborit

Research Interests

Explore related searches

Contact this professor

Articles (10)

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

Circulating Regulatory T Cells Expressing Tumor Necrosis Factor Receptor Type 2 Contribute to Sepsis-Induced Immunosuppression in Patients During Septic Shock.

Treatment of UTIs Due to <i>Klebsiella pneumoniae</i> Carbapenemase-Producers: How to Use New Antibiotic Drugs? A Narrative Review

Epidemiology and clinical impact of respiratory co-infections at diagnosis of Pneumocystis jirovecii Pneumonia

Contribution of lung ultrasound in diagnosis of community-acquired pneumonia in the emergency department: a prospective multicentre study.

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.

Pharmacokinetics and safety of XAV-19, a Swine Glycohumanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-related moderate pneumonia: A randomized, double-blind, placebo-controlled, phase IIa Study

Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia.

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.

Collaborators (9)

Roberto Roncon‐Albuquerque

Ted Steiner

Antoine ASQUIER-KHATI

Benoit Salomon

Xavier MONNET

Giacomo Maria Guidelli

Antoine Roquilly

Philippe Le Conte

Fabian Dusse

Make your next move.